Genelux Corp. GNLX
NASDAQ · United States · Health Technology
$2.49-0.04 (-1.58%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.21 | -0.20 | -6.8% | $0 | — | +1.5%$2.70→$2.74 |
| Q1 2026 | 2026-05-07 | -0.20 | -0.18 | -11.1% | — | — | +8.4%$2.87→$3.11 |
| Q4 2025 | 2026-03-19 | -0.24 | -0.22 | -9.1% | — | — | -7.3%$2.59→$2.40 |
| Q3 2025 | 2025-11-05 | -0.21 | -0.23 | +8.7% | — | — | -34.6%$8.11→$5.30 |
| Q4 2024 | 2025-03-28 | -0.26 | -0.18 | -44.4% | — | — | — |
| Q4 2023 | 2024-03-29 | -0.25 | -0.18 | -38.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.